Anabolic effects on bone mass of oestrogen treatment in a transsexual male;Osteoanabole ostrogentherapie bei einem transsexuellen mann

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 17, 1999, Pages 519-522

  Hierl, Thomas ^a   Börcsök, Irma ^a   Ziegler, Reinhard ^a   Kasperk, Christian ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROTERONE; ESTRADIOL VALERATE; ESTROGEN; TESTOSTERONE;

ADULT; ARTICLE; BONE BIOPSY; BONE MASS; BONE METABOLISM; BONE TURNOVER; CASE REPORT; CELL STIMULATION; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; HORMONAL REGULATION; HUMAN; MALE; OSTEOBLAST; OSTEOPOROSIS; TESTOSTERONE BLOOD LEVEL; TRANSSEXUALISM;

EID: 0033617226     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024353     Document Type: Article

References (24)

1. Bonjour, J. P., G. Theintz, B. Buchs, D. Slosman, R. Rizzoli: Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J. Clin. Endocrinol. Metab. 73 (1991), 555-563.
2. Carani, C., K. Qin, M. Simoni, M. Faustini-Fustini, S. Serpente, J. Boyd, K. Korach, E. Simpson: Effect of testosterone and estradiol in a man with aromatase deficiency. New Engl. J. Med. 337 (1997), 91-95.
3. Donaldson, C. L., S. B. Hulley, J. M. Vogel, R. S. Hattner, J. H. Bayers, D. E. McMillan: Effect of prolonged bed rest on bone mineral. Metabolism 19 (1970), 1071-1084.
4. Felson, D. T., Y. Zhang, M. T. Hannan, W. B. Karmel, D. P. Kiel: Alcohol intake and bone mineral density in elderly men and women. The Framingham study. Amer. J. Epidemiol. 142 (1995), 485-492.
5. Francis, R. M., M. Peacock, D. H. Marshall, A. Horsman, J. E. Aaron: Spinal osteoporosis in men. Bone Miner. 5 (1989), 347-357.
6. Greendale, G. A., E. Sharon, E. Barrett-Connor: Endogenous sex steroids and bone mineral density in older women and men. The Rancho Bernardo study. J. Bone Miner. Res. 11 (1997), 1833-1842.
7. Hannan, M. T., D. T. Felson, J. J. Anderson: Bone mineral density in elderly men and women: Results from the Framingham osteoporosis study. J. Bone Miner. Res. 7 (1992), 547-553.
8. Honasoge, M., D. S. Rao: Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr. Opin. Rheumatol. 6 (1995), 249-254.
9. Kasperk, C., U. Schneider, U. Sommer, F. Niethard, R. Ziegler: Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro. Calcif. Tissue. Int. 81 (1995), 120-126.
10. Kasperk, C., R. Fitzsimmons, D. Strong, S. Mohan, J. Jennings, J. Wergedal, D. Baylink: Studies of the mechanism by which androgensenhance mitogenesis and differentiation in bone cells. J. Clin. Endocrinol. Metab. 71 (1990), 1322-1329.
11. Kasperk, C., G. Wakley, T. Hierl, R. Ziegler: Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J. Bone Miner. Res. 12 (1997), 464-471.
12. Katznelson, L., J. S. Finkelstein, D. A. Schoenfeld, D. I. Rosenthal, E. J. Anderson, A. Klibanski: Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J. Clin. Endocrinol. Metab. 81 (1996), 4358-4365.
13. Kelepouris, N., K. D. Harper, F. Gannon, F. S. Kaplan, J. G. Haddad: Severe osteoporosis in men. Ann. Intern. Med. 123 (1995), 452-460.
14. Kiel, D. P., Y. Zhang, M. T. Hannan, J. J. Anderson, J. A. Baron, D. T. Felson: The effect of smoking at different life stages on bone mineral density in elderly men and women. Osteoporos. Int. 6 (1996), 240-248.
15. Krall, E. A., B. Dawson-Hughes: Heritable and life-style determinants of bone mineral density. J. Bone Miner. Res. 8 (1993), 1-9.
16. O'Neill, T. W., D. Felsenberg, J. Varlow, C. Cooper, J. A. Kanis, A. J. Silman: The prevalence of vertebral deformity in european men and women. The European Vertebral Osteoporosis study. J. Bone Miner. Res. 11 (1996), 1010-1018.
17. Rosen, C. J.: Endocrine disorders and osteoporosis. Curr. Opin. Rheumatol. 9 (1997), 355-361.
18. Schweikert, H., L. Wolf, G. Romalo: Oestrogen formation from androstenedione in human bone. Clin. Endocrinol. 43 (1995), 37-42.
19. Seeman, E., L. J. Melton, W. M. O'Fallon, B. L. Riggs: Risk factors for spinal osteoporosis in men. Amer. Med. 75 (1983), 977-983.
20. Slemenda, C., C. Longcope, L. Zhou, S. Hui, M. Peacock, C. Johnston: Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J. Clin. Invest. 100 (1997), 1755-1759.
21. Smith, E. P., J. Boyd, G. R. Frank, H. Takahashi, R. M. Cohen, B. Spekker, T. C. Williams, D. B. Lubahn, K. S. Korach: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New Engl. J. Med. 331 (1994), 1056-1061.
22. Stepan, J. J., M. Lachman, J. Zverina, V. Pacovsky, D. J. Baylink: Castrated men exhibit bone loss. Effect of calcitonin treatment on biochemical indices of bone remodeling. J. Clin. Endocrinol. Metab. 69 (1989), 523-527.
23. van Kesteren, P., P. Lips, W. Deville, C. Popp-Snijders, H. Asscheman, J. Megens, L. Gooren: The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals. J. Clin. Endocrinol. Metab. 81 (1996), 2227-2232.
24. Zerwekh, J. E., K. Sakhaee, N. A. Breslau, F. Gottschalk, C. Y. Pak: Impaired bone formation in male idiopathic osteoporosis. Further reduction in the presence of concomitant hypercalciuria. Osteoporos. Int. 2 (1992), 128-134.